These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4285237)

  • 41. Comparison of the development of resistant strains of Type 1 herpes simplex virus to in vitro antiviral activity of 5-iodo-2'-deoxyuridine or ribavirin.
    Huffman JH; Allen LB; Sidwell RW
    Ann N Y Acad Sci; 1977 Mar; 284(1):233-8. PubMed ID: 212974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of spontaneous and induced thymidine and 5-iodo-2-deoxyuridine resistant clones of mouse lymphoma cells.
    Fox M; Anderson D
    Mutat Res; 1974 Oct; 25(1):89-105. PubMed ID: 4530153
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug resistance and antiviral agents.
    McGill J
    J Antimicrob Chemother; 1977 May; 3(3):284-5. PubMed ID: 194878
    [No Abstract]   [Full Text] [Related]  

  • 44. Cross-resistances to antiviral drugs of IUdR-resistant HSV1 in rabbit keratitis and in vitro.
    Fardeau C; Langlois M; Nugier F; Asselot C; Aymard M; Denis J
    Cornea; 1993 Jan; 12(1):19-24. PubMed ID: 8384543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracellular pools of thymidine reduce the antiviral action of acyclovir.
    Harmenberg J
    Intervirology; 1983; 20(1):48-51. PubMed ID: 6307920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acyclovir-resistant, pathogenic herpesviruses.
    Coen DM
    Trends Microbiol; 1994 Dec; 2(12):481-5. PubMed ID: 7889324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered thymidylate kinase substrate specificity in mammalian cells selected for resistance to iododeoxyuridine.
    Kaufman ER; Davidson RL
    Exp Cell Res; 1979 Oct; 123(2):355-63. PubMed ID: 499362
    [No Abstract]   [Full Text] [Related]  

  • 48. Basic biochemical and pharmacological aspects of antiviral agents.
    Prusoff WH; Zucker M; Mancini WR; Otto MJ; Lin TS; Lee JJ
    Antiviral Res; 1985; Suppl 1():1-10. PubMed ID: 3002248
    [No Abstract]   [Full Text] [Related]  

  • 49. Trifluorothymidine and idoxuridine therapy of ocular herpes.
    Pavan-Langston D; Foster CS
    Am J Ophthalmol; 1977 Dec; 84(6):818-25. PubMed ID: 413436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virus-induced thymidine kinases as markers for typing herpes simplex viruses and for drug sensitivity assays.
    Cheng YC; Schinazi RF; Dutschman GE; Tan RS; Grill SP
    J Virol Methods; 1982 Nov; 5(3-4):209-17. PubMed ID: 6296179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
    Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
    Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ara-A and IDU therapy of human superficial herpetic keratitis.
    Laibson PR; Hyndiuk R; Krachmer JH; Schultz RO
    Invest Ophthalmol; 1975 Oct; 14(10):762-3. PubMed ID: 1102484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A perspective on resistance to acyclovir in herpes simplex virus.
    Field HJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():129-35. PubMed ID: 6313592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reversibility of IUdR resistance to sensitivity to an HSV1 strain in experimental keratitis in rabbits].
    Fardeau C; Langlois M; Ingrand D; Asselot C; Moret H; Nugier F
    C R Acad Sci III; 1992; 314(10):443-9. PubMed ID: 1325862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.
    Collum LM; Benedict-Smith A; Hillary IB
    Br J Ophthalmol; 1980 Oct; 64(10):766-9. PubMed ID: 7000171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
    Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS.
    KAUFMAN HE; HEIDELBERGER C
    Science; 1964 Aug; 145(3632):585-6. PubMed ID: 14163783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers.
    Wellings PC; Awdry PN; Bors FH; Jones BR; Brown DC; Kaufman HE
    Am J Ophthalmol; 1972 Jun; 73(6):932-42. PubMed ID: 4555825
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of herpesvirus type 1 thymidine kinase in experimental ocular infections.
    Gordon YJ; Armstrong JA; Brown SI; Becker Y
    Am J Ophthalmol; 1983 Feb; 95(2):175-81. PubMed ID: 6824049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.